More expansion for QPS in Asia through intellim JV

CROs QPS and intellim team for Japan JV
CROs QPS and intellim team for Japan JV

Related tags Clinical trial

QPS Holdings has set up a joint venture (JV) partnership with intellim Corporation to set up a new CRO in Japan.

The new entity - iQ Pharma Services Corporation – will provide Phase II to Phase IV clinical research services in Japan, South Korea, Taiwan and China and is expected to be fully operational later this year.

Masakuni Ukita, CEO of Japan-based intellim, said: “This alliance validates the strength of intellim's service portfolio and reputation, and the power of our business model to enable us to partner with other companies to promote our services.

Because Japan is the second largest country for pharmaceutical companies in terms of new drug development and sales and is interested in expanding its business to Asia and the other regions, we decided to base iQ Pharma Services in Japan. We believe iQ Pharma Services will quickly become essential to the pharmaceutical industry​.”

QPS CEO Ben Chien was similarly positive about the accord, predicting that “iQ Pharma Services will become the CRO of choice for Phase II through Phase IV contract clinical research in the Asia Pacific region.

He added that the “alliance with intellim is the perfect addition to further our own evolution as a global CRO. We are already seeing increased regional demand and we believe this alliance with intellim will allow us to intensify our presence in the Asia Pacific region​."

Expansion

The JV is QPS’ second Asian expansion in just over two months behind the new office in Beijing, China​ that was established by its QPS Qualitix​ subsidiary in October.

It also follows just a month after QPS bolstered its presence in Europe through the expansion of its Phase I clinical trial services facility in the Netherlands​ and the acquisition of Austria-based contract research organisation JSW Life Sciences.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars